Taking the final step from the bench to the hospital or clinic bedside

May 18, 2010

A new Regenstrief Institute and Indiana University Center for Aging Research (IUCAR) study provides effective strategies to help hospital systems, physicians and other care providers to overcome end zone hurdles and actually take evidence-based research to the patient's hospital or clinic bedside.

The paper has been published online by the Journal of Clinical Interventions in Aging, a peer-reviewed, open access publication.

"Much good evidence-based research is conducted and published in peer reviewed publications every year. But unfortunately it's not making its way into medical practice. For example, after numerous studies, the in 1996 approved donepezil, a medication for Alzheimer disease. Yet today, doctors are prescribing this drug to less than 20 percent of eligible individuals," said first author Malaz Boustani, M.D., IU School of Medicine associate professor of medicine. He is a Regenstrief Institute investigator and an IUCAR center scientist.

"Physicians and other health-care providers need help. Our work provides a blueprint emphasizing how to conduct a non-hierarchical group approach to making that last and most important leap from to the real world," added Dr. Boustani.

The paper includes a case study of the Care Medical Home (ABC-MedHome), which has successfully brought evidence-based medicine to both the patient and the family caregiver. The program identifies, assesses and manages the biopsychosocial needs of older patients suffering from dementia or depression (and those of their family caregivers) receiving care within the primary care practice with Wishard Health Service, an urban public health care system.

To use the example of a relay race, the model outlined in the JCIA paper enables the doctors, nurses, social workers, administrators and others who directly provide care to patients to seize the baton and provide locally sensitive treatment based on evidence-based research.

"And with so many policy changes, providers can't do things the way they have always done them. Our paper offers a process to help them select evidence-based modifications and innovations to how they provide and evaluate care to ensure that patients receive the best care possible," said Dr. Boustani.

Explore further: Supplement maker admits lying about ingredients

Provided by Indiana University School of Medicine

not rated yet
add to favorites email to friend print save as pdf

Related Stories

Dementia screening in primary care: Is it time?

Nov 27, 2007

Primary care physicians should focus on "dementia red flags" rather than routinely screen individuals with no dementia symptoms just because they've reached a certain age, according to Malaz Boustani, M.D., MPH, of the Indiana ...

Does universal health care affect attitude toward dementia?

Jan 15, 2009

A new study has found that in spite of their universal health care system which facilitates access to free dementia care, older adults in the United Kingdom are less willing to undergo dementia screening than their counterparts ...

Recommended for you

New approach to particle therapy dosimetry

2 hours ago

Researchers at the National Physical Laboratory (NPL), in collaboration with EMRP partners, are working towards a universal approach to particle beam therapy dosimetry.

Supplement maker admits lying about ingredients

Dec 17, 2014

Federal prosecutors say the owner and president of a dietary supplement company has admitted his role in the sale of diluted and adulterated dietary ingredients and supplements sold by his company.

User comments : 0

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.